Beximco Pharmaceuticals

Activities: Manufacturing Drug Delivery Pharmaceutical

Trending Articles

  1. IMPACT CKD model reveals the escalating toll of chronic kidney disease The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
  2. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  3. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  4. Building strong foundations for a resilient and planet-friendly future Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI...
  5. ten23 health and Ypsomed collaborate to commercialise the YpsoDose patch injector The partnership will bring the drug delivery device to the pharmaceutical market quicker, whilst reducing development risks

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Ingredients

Beximco Pharma receives US FDA approval for antiarryhtmic drug Flecainide

Marks the company's eighth product approval for the US market
Ingredients

Beximco Pharma introduces first generic remdesivir for COVID-19

Beximco Pharma is donating remdesivir (Bemsivir) to the Bangladesh Government for supply only to Government hospitals
Personal Protection

Beximco Pharma donates PPE for the COVID-19 fight

Bangladeshi group has contributed $1.8 million to support this initiative
Finance

Mylan chooses Beximco for exclusive antibody distribution in Bangladesh

Beximco Pharma has received the exclusive rights to launch Netherlands-based Mylan’s portfolio of key monoclonal antibodies in its headquarters of Bangladesh
Manufacturing

Beximco Pharma: The Bangladeshi company connecting with the US

COO Rabbur Reza talks about the strategy behind approaching pharmaceutical manufacturing from an emerging market
Regulatory

Beximco receives FDA approval for generic allergy drug

The nod for Bangladesh-based company is for the antihistamine drug, Cyproheptadine Hydrochloride, a generic equivalent of Periactin tablets form Merck
Regulatory

Beximco Pharma gets eight ANDAs from Sandoz

Deal with Novartis' division to boost Beximco's export sales to the US
Subscribe now